Clinical Response Of Lebrikizumab By Disease Duration: Results From Two Phase 3 Monotherapy Studies
AuthID
P-00Z-JK9
P-00Z-JK9
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service